Opdivo-Yervoy

Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset
Fierce Pharma
Sun, 01/21/24 - 05:09 pm
Bristol Myers Squibb
colorectal cancer
Opdivo-Yervoy
BMS, Synairgen Regroup After Trials Miss Primary Endpoints
BioSpace
Mon, 05/16/22 - 10:36 am
Bristol Myers Squibb
NCT03036098
Opdivo-Yervoy
metastatic urothelial carcinoma
clinical trials
Synairgen